For most people, the word cancer implies that there’s a tumor or mass growing somewhere in the body. However, contrary to ...

A new study aims to investigate the feasibility and impact of multidisciplinary prehabilitation in adults with acute myeloid ...

Sangeetha Venugopal, MD, MS, discussed the evolving landscape of acute myeloid leukemia treatment as well as unmet needs ...

The following is a summary of “Impact of critical illness on continuation of anticancer treatment and prognosis of patients with aggressive hematological malignancies,” published in the September 2024 ...

The NHS England has announced the routine commissioning of Daiichi Sankyo's quizartinib for acute myeloid leukaemia (AML).

The study did not provide details on the proportion of patients with therapy-related or secondary acute myeloid leukaemia, and on those with a poor or intermediate-risk karyotype. Complete remission ...

More than 70,000 people in India died from blood cancer ... Blood cancers primarily fall into three main categories: leukemia ...

Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of Antibody Radiation Conjugates (ARCs) and other targeted radiotherapies, today announced ...

Nearly 2 million people in the United States are living with a form of blood cancer. September marks National Blood Cancer ...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today the approval of the Investigational New ...

“‘Hispanic’ is a very diverse group of people. It’s an ethnicity ... Guzman then referenced a study from 2018 that had major ...

According to new research, 80% of patients with previously untreated or relapsed/refractory advanced-phase chronic myeloid leukemia (CML) -- including both accelerated or myeloid blast phases of the ...